Grossman, Henderson honored by international blood association
Recognized for research on convalescent plasma, COVID-19
The Association for the Advancement of Blood & Biotherapies recently honored Brenda J. Grossman, MD, and Jeffrey P. Henderson, MD, PhD, noted researchers at Washington University School of Medicine in St. Louis, with a 2021 President’s Award.
Grossman, a professor of pathology & immunology and of medicine, and Henderson, an associate professor of medicine and of molecular microbiology, were recognized for their work as part of the COVID-19 Convalescent Plasma Project Group, which helped to advance the science regarding therapeutic options for convalescent plasma.
Convalescent plasma involves transfusing antibodies from the blood of patients who have recovered from an infectious disease — in this case, COVID-19 — into patients who are ill with the virus, to help treat the infection. Grossman and Henderson have contributed to several studies about convalescent plasma and COVID-19. One study found that convalescent plasma from recovered COVID-19 patients can dramatically improve the likelihood of survival among blood cancer patients hospitalized with the virus.
The Association for the Advancement of Blood & Biotherapies is a nonprofit organization dedicated to advancing the field. For more information on the award, please see here.
